Also strongly associated with lncRNA-Topic 4 we found GATA3-AS1, a lncRNA recently proposed as a predictive biomarker of nonresponsive breast cancer patients to neoadjuvant chemotherapy [43]. The gene discussed is GATA3; the disease is breast carcinoma.